International journal of surgery case reports · 2025
A case of colon cancer with secondary pancreatic head metastasis treated via radioactive iodine-125 seed implantation.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Cheng-Wei, Zheng Jian, Zhuang Jing-Zheng, Ruan Lei, Xiang Xin, Li Qing-Chun
Аннотация
INTRODUCTION: Metastatic pancreatic tumors are rare, accounting for only 2 % of pancreatic malignancies, with colon cancer representing just 1.3 % of these cases. Currently, there is no consensus on the therapeutic approach for secondary pancreatic metastasis from colon cancer.
PRESENTATION OF CASE: This report details the treatment of an 81-year-old female patient with secondary pancreatic head metastasis from colon cancer. In December 2023, the patient underwent ultrasound-guided percutaneous puncture radioactive Iodine-125 seed implantation radiotherapy. The procedure was successful, with no significant complications. Follow-up at seven months post-procedure showed complete regression of the pancreatic lesion, and the patient remained in good health at nine months.
DISCUSSION: Colon cancer commonly metastasizes to lymph nodes, liver, lungs, and bones, with pancreatic metastasis being rare. Treatment for pancreatic metastases is complex, but Iodine-125 seed implantation has shown good efficacy for colorectal cancer-related pancreatic metastases. This minimally invasive method offers effective tumor control and recovery.
CONCLUSION: These findings suggest that Iodine-125 seed implantation is a promising, minimally invasive approach for managing pancreatic metastasis secondary to colorectal cancer, providing effective local control and favorable recovery outcomes.
PRESENTATION OF CASE: This report details the treatment of an 81-year-old female patient with secondary pancreatic head metastasis from colon cancer. In December 2023, the patient underwent ultrasound-guided percutaneous puncture radioactive Iodine-125 seed implantation radiotherapy. The procedure was successful, with no significant complications. Follow-up at seven months post-procedure showed complete regression of the pancreatic lesion, and the patient remained in good health at nine months.
DISCUSSION: Colon cancer commonly metastasizes to lymph nodes, liver, lungs, and bones, with pancreatic metastasis being rare. Treatment for pancreatic metastases is complex, but Iodine-125 seed implantation has shown good efficacy for colorectal cancer-related pancreatic metastases. This minimally invasive method offers effective tumor control and recovery.
CONCLUSION: These findings suggest that Iodine-125 seed implantation is a promising, minimally invasive approach for managing pancreatic metastasis secondary to colorectal cancer, providing effective local control and favorable recovery outcomes.